There are lots of different gene abnormalities that predispose people to certain cancers, and we find them. Our work affects a patient's entire family too, and that's a big concern for many that come to us.
Medical Oncology, Hematology and Internal Medicine
George Washington Medical Center, Medical Oncology and Hematology
Mount Sinai Hospital
Albert Einstein College of Medicine
Johns Hopkins University
Hereditary cancer risk assessment, breast cancer treatment, hematology
Dr. Rodriguez attended Johns Hopkins University where she was awarded a Bachelor of Science degree with honors in biomedical engineering and was a member of the Tau Beta Pi Engineering Honor Society. She received her medical degree from Albert Einstein College of Medicine where she was a member of the Alpha Omega Alpha Honor Medical Society. Dr. Rodriguez then completed her residency in Internal Medicine at Mount Sinai Hospital in New York and her fellowship in Hematology and Oncology at George Washington Medical Center in Washington, D.C.
Dr. Rodriguez currently heads the Virginia Cancer Specialists Hereditary Cancer Risk Assessment Program and regularly speaks on the subject of genetics. She is Co-Director of The US Oncology GREAT (Genetic Risk Evaluation and Treatment Program) Executive Committee and has been a member since 2013. Dr. Rodriguez remains active in other areas of the medical community as well. She serves as a Clinical Assistant Professor at Georgetown University Medical Center, she is Chair of the Department of Medicine at Virginia Hospital Center, a member of the ASCO Cancer Prevention Committee, a Member of The Board of Directors at CareFirst BCBS and is involved with the Arlington Free Clinic. Her professional memberships include the American Society of Clinical Oncology and the American Society of Hematology.
Born in Montevideo, Uruguay, Dr. Rodriguez speaks both fluent Spanish and French. She enjoys music and plays guitar in an Irish band.
Dr. Patricia Rodriguez speaks at Tigerlily’s 6th Annual Young Women’s Breast Health Day on the HillRead More
BRCA1/2 mutations and risk‐reducing bilateral salpingo‐oophorectomy among Latinas: The UPTAKE studyRead More
PARP Inhibitors in the Management of Ovarian Cancer: ASCO GuidelineRead More
How the USPSTF Genetic Testing Update for BRCA-Related Cancers Impacts CareRead More
Relationship Between Hereditary Cancer Syndromes and Oncotype DX Recurrence Score.Read More